If you made any changes in Pure these will be visible here soon.

Personal profile


  • 2010-2015 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
  • 1993-2000 M.D., School of Medicine, Taipei Medical University


  • 2016.03- Assistant Professor, Department of Surgery, School of Medicine, Taipei Medical University
  • 2007.08-2008.06 Attending Physician, Taipei Medical University Hospital
  • 2002.07-2007.06 Resident  Physician, Linkou Chang Gung Memorial Hospital 

Fingerprint Dive into the research topics where Chih-Ming Su is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 47 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences
Randomized Controlled Trials Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Arthralgia Medicine & Life Sciences
Acupuncture Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2018


Su, C.


Project: A - Government Institutionb - Ministry of Science and Technology


Su, C.


Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2007 2019

  • 170 Citations
  • 9 h-Index
  • 13 Article
  • 1 Letter
  • 1 Review article

Reply to correspondence concerning “Acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer”

Tam, K. W., Chen, L., Lin, C. C., Huang, T. W., Kuan, Y. C., Huang, Y. H., Chen, H. C., Kao, C. Y. & Su, C. M., Jun 1 2019, In : Breast. 45, p. 119-120 2 p.

Research output: Contribution to journalLetter

Aromatase Inhibitors
Breast Neoplasms
18 Citations (Scopus)
Aromatase Inhibitors
Randomized Controlled Trials
13 Citations (Scopus)

Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer

Hsieh, C. L., Ma, H. P., Su, C-M., Chang, Y. J., Hung, W. Y., Ho, Y. S., Huang, W. J. & Lin, R. K., Apr 15 2016, In : Life Sciences. 151, p. 7-14 8 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Cell Movement
Breast Neoplasms
3 Citations (Scopus)

A novel application of E1A in combination therapy with EGFR- TKI treatment in breast cancer

Su, C. M., Chang, T. Y., Hsu, H. P., Lai, H. H., Li, J. N., Lyu, Y. J., Kuo, K. T., Huang, M. T., Su, J. L. & Chen, P. S., 2016, In : Oncotarget. 7, 39, p. 63924-63936 13 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Breast Neoplasms
Genetic Therapy
Protein-Tyrosine Kinases
17 Citations (Scopus)

MiR-520h is crucial for DAPK2 regulation and breast cancer progression

Su, C-M., Wang, M. Y., Hong, C., Chen, H-A., Su, Y. H., Wu, C-H., Huang, M-T., Chang, Y. W., Jiang, S. S., Sung, S-Y., Chang, J. Y., Chen, L. T., Chen, P. S. & Su, J. L., Mar 3 2016, In : Oncogene. 35, 9, p. 1134-1142 9 p.

Research output: Contribution to journalArticle

Death-Associated Protein Kinases
Breast Neoplasms
Drug Resistance
3' Untranslated Regions